Titre : Saccharomyces

Saccharomyces : Questions médicales fréquentes

Termes MeSH sélectionnés :

Muscle Development
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Saccharomyces : Questions médicales les plus fréquentes", "headline": "Saccharomyces : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Saccharomyces : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-30", "dateModified": "2025-02-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Saccharomyces" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Levures", "url": "https://questionsmedicales.fr/mesh/D015003", "about": { "@type": "MedicalCondition", "name": "Levures", "code": { "@type": "MedicalCode", "code": "D015003", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.300.930" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Saccharomyces boulardii", "alternateName": "Saccharomyces boulardii", "url": "https://questionsmedicales.fr/mesh/D000069983", "about": { "@type": "MedicalCondition", "name": "Saccharomyces boulardii", "code": { "@type": "MedicalCode", "code": "D000069983", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.300.930.705.328" } } }, { "@type": "MedicalWebPage", "name": "Saccharomyces cerevisiae", "alternateName": "Saccharomyces cerevisiae", "url": "https://questionsmedicales.fr/mesh/D012441", "about": { "@type": "MedicalCondition", "name": "Saccharomyces cerevisiae", "code": { "@type": "MedicalCode", "code": "D012441", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.300.930.705.655" } } } ], "about": { "@type": "MedicalCondition", "name": "Saccharomyces", "alternateName": "Saccharomyces", "code": { "@type": "MedicalCode", "code": "D012440", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Chuanbo Zhang", "url": "https://questionsmedicales.fr/author/Chuanbo%20Zhang", "affiliation": { "@type": "Organization", "name": "School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, China." } }, { "@type": "Person", "name": "Wenyu Lu", "url": "https://questionsmedicales.fr/author/Wenyu%20Lu", "affiliation": { "@type": "Organization", "name": "School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, China. wenyulu@tju.edu.cn." } }, { "@type": "Person", "name": "Yi Tang", "url": "https://questionsmedicales.fr/author/Yi%20Tang", "affiliation": { "@type": "Organization", "name": "Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, United States; Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095, United States. Electronic address: yitang@ucla.edu." } }, { "@type": "Person", "name": "Jean-Marc Daran", "url": "https://questionsmedicales.fr/author/Jean-Marc%20Daran", "affiliation": { "@type": "Organization", "name": "Department of Biotechnology, Delft University of Technology, Delft, The Netherlands." } }, { "@type": "Person", "name": "Shifan He", "url": "https://questionsmedicales.fr/author/Shifan%20He", "affiliation": { "@type": "Organization", "name": "School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Fibrous protein composite scaffolds (3D) for tissue regeneration: An in vitro study on skeletal muscle regeneration.", "datePublished": "2022-06-26", "url": "https://questionsmedicales.fr/article/35816880", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.colsurfb.2022.112656" } }, { "@type": "ScholarlyArticle", "name": "Clearance of defective muscle stem cells by senolytics restores myogenesis in myotonic dystrophy type 1.", "datePublished": "2023-07-19", "url": "https://questionsmedicales.fr/article/37468473", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-023-39663-3" } }, { "@type": "ScholarlyArticle", "name": "Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitors.", "datePublished": "2023-11-14", "url": "https://questionsmedicales.fr/article/37963071", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7554/eLife.87081" } }, { "@type": "ScholarlyArticle", "name": "Ascorbic acid reduces Ropivacaine-induced myotoxicity in cultured human osteoporotic skeletal muscle cells.", "datePublished": "2023-07-15", "url": "https://questionsmedicales.fr/article/37454045", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12891-023-06702-5" } }, { "@type": "ScholarlyArticle", "name": "From cyclins to CDKIs: Cell cycle regulation of skeletal muscle stem cell quiescence and activation.", "datePublished": "2022-08-02", "url": "https://questionsmedicales.fr/article/35931143", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.yexcr.2022.113275" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Champignons", "item": "https://questionsmedicales.fr/mesh/D005658" }, { "@type": "ListItem", "position": 4, "name": "Levures", "item": "https://questionsmedicales.fr/mesh/D015003" }, { "@type": "ListItem", "position": 5, "name": "Saccharomyces", "item": "https://questionsmedicales.fr/mesh/D012440" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Saccharomyces - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Saccharomyces", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Saccharomyces", "description": "Comment identifier une infection par Saccharomyces ?\nQuels tests sont utilisés pour diagnostiquer Saccharomyces ?\nQuels symptômes indiquent une infection par Saccharomyces ?\nLes tests sanguins sont-ils utiles pour Saccharomyces ?\nComment différencier Saccharomyces d'autres levures ?", "url": "https://questionsmedicales.fr/mesh/D012440?mesh_terms=Muscle+Development&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Saccharomyces", "description": "Quels sont les symptômes d'une surcroissance de Saccharomyces ?\nSaccharomyces peut-il causer des allergies ?\nY a-t-il des symptômes cutanés liés à Saccharomyces ?\nLes symptômes varient-ils selon l'âge ?\nSaccharomyces peut-il affecter le système immunitaire ?", "url": "https://questionsmedicales.fr/mesh/D012440?mesh_terms=Muscle+Development&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Saccharomyces", "description": "Comment éviter une surcroissance de Saccharomyces ?\nLes habitudes alimentaires influencent-elles Saccharomyces ?\nFaut-il éviter certains aliments pour prévenir Saccharomyces ?\nL'hygiène personnelle est-elle importante ?\nLes probiotiques aident-ils à prévenir Saccharomyces ?", "url": "https://questionsmedicales.fr/mesh/D012440?mesh_terms=Muscle+Development&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Saccharomyces", "description": "Quels traitements sont efficaces contre Saccharomyces ?\nPeut-on utiliser des remèdes naturels contre Saccharomyces ?\nLes probiotiques sont-ils utiles contre Saccharomyces ?\nQuel est le rôle des antibiotiques dans le traitement ?\nComment prévenir les infections à Saccharomyces ?", "url": "https://questionsmedicales.fr/mesh/D012440?mesh_terms=Muscle+Development&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Saccharomyces", "description": "Quelles complications peuvent survenir avec Saccharomyces ?\nSaccharomyces peut-il causer des infections récurrentes ?\nY a-t-il des risques pour les personnes âgées ?\nLes infections à Saccharomyces peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?", "url": "https://questionsmedicales.fr/mesh/D012440?mesh_terms=Muscle+Development&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Saccharomyces", "description": "Quels sont les principaux facteurs de risque pour Saccharomyces ?\nLe diabète augmente-t-il le risque d'infection par Saccharomyces ?\nLes antibiotiques peuvent-ils être un facteur de risque ?\nLes personnes âgées sont-elles plus à risque ?\nLe stress peut-il influencer le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D012440?mesh_terms=Muscle+Development&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier une infection par Saccharomyces ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par culture et observation microscopique des levures." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour diagnostiquer Saccharomyces ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de culture, PCR et sérologie peuvent être utilisés pour le diagnostic." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection par Saccharomyces ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des douleurs abdominales et des troubles digestifs." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles pour Saccharomyces ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent détecter des anticorps contre Saccharomyces." } }, { "@type": "Question", "name": "Comment différencier Saccharomyces d'autres levures ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse morphologique et les tests biochimiques aident à la différenciation." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une surcroissance de Saccharomyces ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent ballonnements, diarrhée et fatigue." } }, { "@type": "Question", "name": "Saccharomyces peut-il causer des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des allergies aux levures." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés liés à Saccharomyces ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent survenir en cas d'infection systémique." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus graves chez les personnes âgées." } }, { "@type": "Question", "name": "Saccharomyces peut-il affecter le système immunitaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une surcroissance peut affaiblir le système immunitaire, surtout chez les immunodéprimés." } }, { "@type": "Question", "name": "Comment éviter une surcroissance de Saccharomyces ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Limiter la consommation de sucres raffinés et maintenir une flore intestinale saine." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles Saccharomyces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en sucres favorise la prolifération de Saccharomyces." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments pour prévenir Saccharomyces ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments fermentés en excès peut aider à prévenir les infections." } }, { "@type": "Question", "name": "L'hygiène personnelle est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hygiène personnelle réduit le risque d'infections fongiques." } }, { "@type": "Question", "name": "Les probiotiques aident-ils à prévenir Saccharomyces ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les probiotiques peuvent renforcer le système immunitaire et prévenir les infections." } }, { "@type": "Question", "name": "Quels traitements sont efficaces contre Saccharomyces ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antifongiques comme le fluconazole sont souvent utilisés pour traiter les infections." } }, { "@type": "Question", "name": "Peut-on utiliser des remèdes naturels contre Saccharomyces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains remèdes naturels, comme l'ail, peuvent aider à contrôler la croissance." } }, { "@type": "Question", "name": "Les probiotiques sont-ils utiles contre Saccharomyces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les probiotiques peuvent rétablir l'équilibre intestinal et réduire les symptômes." } }, { "@type": "Question", "name": "Quel est le rôle des antibiotiques dans le traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques ne sont pas efficaces contre les levures comme Saccharomyces." } }, { "@type": "Question", "name": "Comment prévenir les infections à Saccharomyces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et éviter les excès de sucre peut aider à prévenir." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec Saccharomyces ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des infections systémiques graves peuvent survenir, surtout chez les immunodéprimés." } }, { "@type": "Question", "name": "Saccharomyces peut-il causer des infections récurrentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections récurrentes peuvent se produire si les facteurs de risque persistent." } }, { "@type": "Question", "name": "Y a-t-il des risques pour les personnes âgées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées sont plus susceptibles de développer des complications graves." } }, { "@type": "Question", "name": "Les infections à Saccharomyces peuvent-elles être mortelles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Dans des cas extrêmes, surtout chez les immunodéprimés, elles peuvent être mortelles." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications nécessitent souvent une hospitalisation et un traitement antifongique intensif." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour Saccharomyces ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'immunodépression, le diabète et une alimentation riche en sucres." } }, { "@type": "Question", "name": "Le diabète augmente-t-il le risque d'infection par Saccharomyces ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète favorise la croissance de Saccharomyces et augmente le risque d'infection." } }, { "@type": "Question", "name": "Les antibiotiques peuvent-ils être un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation d'antibiotiques peut perturber la flore et favoriser Saccharomyces." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un système immunitaire affaibli, augmentant le risque." } }, { "@type": "Question", "name": "Le stress peut-il influencer le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection." } } ] } ] }

Sources (10000 au total)

Ascorbic acid reduces Ropivacaine-induced myotoxicity in cultured human osteoporotic skeletal muscle cells.

Osteoporosis is a worldwide health issue. Loss of bone mass is a potential risk factor for fragility fractures, and osteoporotic fractures place a considerable burden on society. Bone and muscle repre... Primary human myoblasts and myotubes from healthy subjects, osteoarthritic and osteoporotic patients (OP) were cultured in the presence of Ropivacaine. In some experiments, ascorbic acid (AsA) was add... A dose-dependent decrease of cell viability was observed after Ropivacaine exposure in both OP myoblasts and myotubes cultures, whereas those effects were not observed in the presence of Propofol, a g... Our findings highlight the oxidative stress-mediated myotoxic effect of Ropivacaine on human skeletal muscle tissue cell cultures, and suggest treatment with AsA as valid strategy to mitigate its nega...

In vitro myogenesis activation of specific muscle-derived stem cells from patients with Duchenne muscular dystrophy.

Muscle-derived stem cells (MDSCs) contribute to the repair of injured muscles. However, the myogenicity of MDSCs generated from patients with Duchenne muscular dystrophy (DMD) relative to healthy indi... A human DMD model was established using the stem cells prepared from muscle derived from patients with DMD (DMD-hMDSCs). The expression of myogenic lineage-specific markers in MDSCs was examined with ... It was demonstrated that, compared with cells from healthy subjects, DMD-hMDSCs are primed to self-differentiate in growth-inducing medium (GM) and robustly differentiate into myotubes in differentiat... The myogenesis activation in DMD-hMDSCs demonstrated in this study may provide novel mechanistic insights into DMD pathogenesis and potential therapies....

Postnatal skeletal muscle myogenesis governed by signal transduction networks: MAPKs and PI3K-Akt control multiple steps.

Skeletal muscle myogenesis represents one of the most intensively and extensively examined systems of cell differentiation, tissue formation, and regeneration. Muscle regeneration provides an in vivo ...

Prolonged FOS activity disrupts a global myogenic transcriptional program by altering 3D chromatin architecture in primary muscle progenitor cells.

The AP-1 transcription factor, FBJ osteosarcoma oncogene (FOS), is induced in adult muscle satellite cells (SCs) within hours following muscle damage and is required for effective stem cell activation... We established an inducible, FOS expression system to evaluate the impact of persistent FOS activity in muscle progenitor cells ex vivo. We performed various assays to measure cellular proliferation a... Persistent FOS activity in primary muscle progenitor cells severely antagonizes their ability to differentiate and form myotubes within the first 2 weeks in culture. RNA-seq analysis revealed that ect... Our results suggest that elevated FOS activity in recently activated muscle progenitor cells perturbs cellular differentiation by altering the 3D chromosome organization near critical pro-myogenic gen...